drugset / Trial / NCT02935725
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
RandomizedCrossoverTriple-blindTreatment
Summary
A Phase 1, Single-centre, Double-blind, Placebo controlled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants
Timeline
- Start
- 2016-10
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AUT00206 | Small molecule | 800 mg | — |
| Subject | AUT00206 | Small molecule | 2000 mg | — |
| Background | Ketamine | Small molecule | — | — |